Pioneering a combinatorial device-drug treatment to promote neuronal regrowth and functional recovery
Drug-eluting electrical implant to repair the spinal cord
Patients and families
DREIMS is a research and innovation project that will refine a novel experimental treatment to repair the spinal cord.
Activities for 2023 to 2026 include testing the technology in animals, with clinical studies on human patients expected for 2027 and beyond.
No recruitment of persons afflicted with spinal cord injury or other neurological diseases will be carried out by any of the participant organisations in the period 2023-2026.
Nevertheless, DREIMS will mature the technology close to human application. Our endeavour is increasing as much as possible the benefit / risk balance for patients before testing the technology in human clinical trials.
